NeoGenomics: 2Q Earnings Snapshot

July 24, 2018

FORT MYERS, Fla. (AP) _ NeoGenomics Inc. (NEO) on Tuesday reported a loss of $380,000 in its second quarter.

The Fort Myers, Florida-based company said it had a loss of 7 cents per share. Earnings, adjusted for one-time gains and costs, were 5 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.

The operator of cancer-focused testing laboratories posted revenue of $67.7 million in the period.

NeoGenomics expects full-year earnings in the range of 12 cents to 17 cents per share, with revenue in the range of $260 million to $272 million.

NeoGenomics shares have risen 58 percent since the beginning of the year. The stock has increased 54 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO

Update hourly